Boston Scientific Corporation BSX.F Stock
Boston Scientific Corporation Price Chart
Boston Scientific Corporation BSX.F Financial and Trading Overview
Boston Scientific Corporation stock price | 64 EUR |
Previous Close | 48.77 EUR |
Open | 48.84 EUR |
Bid | 49.19 EUR x 60000 |
Ask | 49.45 EUR x 60000 |
Day's Range | 48.84 - 48.84 EUR |
52 Week Range | 33.63 - 49.6 EUR |
Volume | 89 EUR |
Avg. Volume | 41 EUR |
Market Cap | 71.17B EUR |
Beta (5Y Monthly) | 0.795774 |
PE Ratio (TTM) | 85.68421 |
EPS (TTM) | 1 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BSX.F Valuation Measures
Enterprise Value | 79.17B EUR |
Trailing P/E | 85.68421 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.455703 |
Price/Book (mrq) | 3.9333172 |
Enterprise Value/Revenue | 6.069 |
Enterprise Value/EBITDA | 24.13 |
Trading Information
Boston Scientific Corporation Stock Price History
Beta (5Y Monthly) | 0.795774 |
52-Week Change | 46.08% |
S&P500 52-Week Change | 20.43% |
52 Week High | 49.6 EUR |
52 Week Low | 33.63 EUR |
50-Day Moving Average | 47.43 EUR |
200-Day Moving Average | 43.78 EUR |
BSX.F Share Statistics
Avg. Volume (3 month) | 41 EUR |
Avg. Daily Volume (10-Days) | 96 EUR |
Shares Outstanding | 1.44B |
Float | 1.43B |
Short Ratio | N/A |
% Held by Insiders | 0.26% |
% Held by Institutions | 93.96% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.91% |
Operating Margin (ttm) | 16.35% |
Gross Margin | 68.67% |
EBITDA Margin | 25.15% |
Management Effectiveness
Return on Assets (ttm) | 4.08% |
Return on Equity (ttm) | 5.17% |
Income Statement
Revenue (ttm) | 13.05B EUR |
Revenue Per Share (ttm) | 9.11 EUR |
Quarterly Revenue Growth (yoy) | 12.00% |
Gross Profit (ttm) | 8.68B EUR |
EBITDA | 3.28B EUR |
Net Income Avi to Common (ttm) | 846M EUR |
Diluted EPS (ttm) | 0.57 |
Quarterly Earnings Growth (yoy) | 185.50% |
Balance Sheet
Total Cash (mrq) | 570M EUR |
Total Cash Per Share (mrq) | 0.4 EUR |
Total Debt (mrq) | 9.37B EUR |
Total Debt/Equity (mrq) | 51.72 EUR |
Current Ratio (mrq) | 1.397 |
Book Value Per Share (mrq) | 12.417 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.77B EUR |
Levered Free Cash Flow (ttm) | 1.17B EUR |
Profile of Boston Scientific Corporation
Country | Germany |
State | MA |
City | Marlborough |
Address | 300 Boston Scientific Way |
ZIP | 01752-1234 |
Phone | 508 683 4000 |
Website | https://www.bostonscientific.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 45000 |
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Q&A For Boston Scientific Corporation Stock
What is a current BSX.F stock price?
Boston Scientific Corporation BSX.F stock price today per share is 64 EUR.
How to purchase Boston Scientific Corporation stock?
You can buy BSX.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Boston Scientific Corporation?
The stock symbol or ticker of Boston Scientific Corporation is BSX.F.
Which industry does the Boston Scientific Corporation company belong to?
The Boston Scientific Corporation industry is Medical Devices.
How many shares does Boston Scientific Corporation have in circulation?
The max supply of Boston Scientific Corporation shares is 1.47B.
What is Boston Scientific Corporation Price to Earnings Ratio (PE Ratio)?
Boston Scientific Corporation PE Ratio is 64.00000000 now.
What was Boston Scientific Corporation earnings per share over the trailing 12 months (TTM)?
Boston Scientific Corporation EPS is 1 EUR over the trailing 12 months.
Which sector does the Boston Scientific Corporation company belong to?
The Boston Scientific Corporation sector is Healthcare.